BumSik Chin

BumSik Chin

Auto-generated profile, based on publicly available information

BumSik Chin

Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JAJin Young Ahn
Jin Young Ahn
YSYujin Sohn
Yujin Sohn
SLSu Hwan Lee
Su Hwan Lee
YCYunsuk Cho
Yunsuk Cho
JHJongHoon Hyun
JongHoon Hyun
JCJun Yong Choi
Jun Yong Choi
Ahn JY, et al. J Korean Med Sci. 2020 Feb;35(14):e149. https://doi.org/10.3346/jkms.2020.35.e149

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EKEu Suk Kim
Eu Suk Kim
BCBum Sik Chin
Bum Sik Chin
CKChang Kyung Kang
Chang Kyung Kang
NKNam Joong Kim
Nam Joong Kim
KYKang Yumin
Kang Yumin
OCon behalf of the Korea National Committee for Clinical Management of COVID-19
on behalf of the Korea National Committee for Clinical Management of COVID-19
Kim ES, et al. J Korean Med Sci. 2020 Feb;35(13):e142. https://doi.org/10.3346/jkms.2020.35.e142

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
JKJin Yong Kim
Jin Yong Kim
JKJae-Hoon Ko
Jae-Hoon Ko
YKYeonjae Kim
Yeonjae Kim
YKYae-Jean Kim
Yae-Jean Kim
JKJeong-Min Kim
Jeong-Min Kim
BCBum Sik Chin
Bum Sik Chin
Kim JY, et al. J Korean Med Sci. 2019 Dec;35(7):e86. https://doi.org/10.3346/jkms.2020.35.e86

1 January 2018 in Journal of Korean Medical Science
Verified
Journal Article
Open access
WPWan Beom Park
Wan Beom Park
KJKang Il Jun
Kang Il Jun
GKGayeon Kim
Gayeon Kim
JCJae-Phil Choi
Jae-Phil Choi
JRJi-Young Rhee
Ji-Young Rhee
HSHyoung-shik Shin
Hyoung-shik Shin
Park WB, et al. J Korean Med Sci. 2018 May;33(24):e169. https://doi.org/10.3346/jkms.2018.33.e169

13 April 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ELEunyoung Emily Lee
Eunyoung Emily Lee
KSKyoung-Ho Song
Kyoung-Ho Song
WHWoochang Hwang
Woochang Hwang
SHSin Young Ham
Sin Young Ham
HJHyeonju Jeong
Hyeonju Jeong
JPJin Kyun Park
Jin Kyun Park
The objective of the study was to identify distinct patterns in inflammatory immune responses of COVID-19 patients and to investigate their association with clinical course and outcome. Data from hospitalized COVID-19 patients were retrieved from electronic medical record. Supervised k-means clustering of serial C-reactive protein levels (CRP), absolute neutrophil counts (ANC), and absolute lymphocyte counts (ALC) was used to assign immune responses to one of three groups. Then, relationships between patterns of inflammatory responses and clinical course and outcome of COVID-19 were assessed in a discovery and validation cohort. Unbiased clustering analysis grouped 105 patients of a discovery cohort into three distinct clusters. Cluster 1 (hyper-inflammatory immune response) was characterized by high CRP levels, high ANC, and low ALC, whereas Cluster 3 (hypo-inflammatory immune response) was associated with low CRP levels and normal ANC and ALC. Cluster 2 showed an intermediate pattern. All patients in Cluster 1 required oxygen support whilst 61% patients in Cluster 2 and no patient in Cluster 3 required supplementary oxygen. Two (13.3%) patients in Cluster 1 died, whereas no patient in Clusters 2 and 3 died. The results were confirmed in an independent validation cohort of 116 patients. We identified three different patterns of inflammatory immune response to COVID-19. Hyper-inflammatory immune responses with elevated CRP, neutrophilia, and lymphopenia are associated with a severe disease and a worse outcome. Therefore, targeting the hyper-inflammatory response might improve the clinical outcome of COVID-19.

8 July 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
TLTaeseob Lee
Taeseob Lee
YKYuri Kim
Yuri Kim
HKHyun Je Kim
Hyun Je Kim
NHNa-Young Ha
Na-Young Ha
SLSiyoung Lee
Siyoung Lee
NCNam-Hyuk Cho
Nam-Hyuk Cho
Background: Despite the use of vaccines and therapeutics against the coronavirus disease 2019 (COVID-19) pandemic, this severe disease has been a critical burden on public health, whereas the pathogenic mechanism remains elusive. Recently, accumulating evidence underscores the potential role of the aberrant B-cell response and humoral immunity in disease progression, especially in high-risk groups.Methods: Using single-cell RNA (scRNA) sequencing analysis, we investigated transcriptional features of B-cell population in peripheral blood from COVID-19 patients and compared them, according to clinical severity and disease course, against a public B-cell dataset.Results: We confirmed that acute B cells differentiate into plasma cells, particularly in severe patients, potentially through enhanced extrafollicular (EF) differentiation. In severe groups, the elevated plasma B-cell response displayed increased B-cell receptor (BCR) diversity, as well as higher levels of anti–severe acute respiratory syndrome coronavirus 2 (anti–SARS-CoV-2) spike antibodies in plasma, than those in moderate cases, suggesting more robust and heterogeneous plasma cell response in severe COVID-19 patients. Trajectory analysis identified a differentiation pathway for the EF B-cell response from active naïve to atypical memory B cells (AM2), in addition to the emergence of an aberrant plasma cell subset (PC2), which was associated with COVID-19 progression and severity. The AM2 and PC2 subsets surged in the acute phase of the severe disease and presented multiple inflammatory features, including higher cytokine expression and humoral effector function, respectively. These features differ from other B-cell subsets, suggesting a pathogenic potential for disease progression.Conclusion: The acute surge of AM2 and PC2 subsets with lower somatic hypermutation and higher inflammatory features may be driven by the EF B-cell response during the acute phase of severe COVID-19 and may represent one of the critical drivers in disease severity.